1st Quarter - Report
THE KPM GROUP DC LLC for RARE DISEASE COMPANY COALITION
Firm
Income
$130,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
S. 1906, the Promising Pathway Act H.R.5539/S.3131, the ORPHAN Cures Act H.R. 7384, the Creating Hope Reauthorization Act H.R.4758/S.2372, the Accelerating Kids Access to Care Act H.R.6664, the Innovation in Pediatric Drugs Act H.R.1184/S.4071, the Helping Experts Accelerate Rare Treatments Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATROSKI LAWSON | — |
| YOKO ROSENBAUM | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.